Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02874664
Title A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stemcentrx
Indications
Therapies
Age Groups: child | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California Los Angeles Los Angeles California 90404 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Parkview Research Center Fort Wayne Indiana 46845 United States Details
Baptist Health Lexington Lexington Kentucky 40503 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
University of Cincinnati Cincinnati Ohio 45267 United States Details
University Hospitals Case Medical Center Cleveland Ohio 44106 United States Details
MetroHealth Medical Center Cleveland Ohio 44109 United States Details
Greenville Health System Cancer Institute Greenville South Carolina 29605 United States Details
Mary Crowley Medical Research Center Dallas Texas 75230 United States Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
The Ottawa Hospital-Cancer Centre Ottawa Ontario K1H 8L6 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field